{"transactions":[{"id":979195,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T08:43:15.000Z","date":"2025-12-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."}],"balance_after":0,"derivative":{"exercise_price":3.43,"expiration_date":"2025-03-02","underlying":"Ordinary Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001193125-25-308739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000119312525308739/ownership.xml","form_type":"4"}},{"id":979194,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T08:43:15.000Z","date":"2025-12-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":146452,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."}],"balance_after":0,"derivative":{"exercise_price":3.61,"expiration_date":"2033-12-13","underlying":"Ordinary Shares","underlying_shares":146452},"source":{"system":"sec-edgar","filing":"0001193125-25-308739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000119312525308739/ownership.xml","form_type":"4"}},{"id":979193,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-05T08:43:15.000Z","date":"2025-12-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":99290,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of the Transaction Agreement (the \"Agreement\"), dated August 20, 2025, by and among the Issuer, XRA 5 Corp. (\"Sub\"), a Delaware corporation and wholly-owned subsidiary of XOMA Royalty Corporation, a Nevada corporation, Sub acquired all the issued and to be issued share capital of the Issuer (the \"Acquisition\") for a cash purchase price of $2.035 per share (the \"Scheme Consideration\"), as of December 5, 2025 (the \"Effective Time\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes the disposition of 77,429 unvested restricted stock units (\"RSUs\"). Pursuant to the Agreement, as of the Effective Time each RSU held by the Reporting Person that was outstanding as of immediately prior to the Effective Time (whether or not vested) was automatically cancelled and converted into the right to receive an amount equal to the Scheme Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Transaction Agreement (the \"Agreement\"), dated August 20, 2025, by and among the Issuer, XRA 5 Corp. (\"Sub\"), a Delaware corporation and wholly-owned subsidiary of XOMA Royalty Corporation, a Nevada corporation, Sub acquired all the issued and to be issued share capital of the Issuer (the \"Acquisition\") for a cash purchase price of $2.035 per share (the \"Scheme Consideration\"), as of December 5, 2025 (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes the disposition of 77,429 unvested restricted stock units (\"RSUs\"). Pursuant to the Agreement, as of the Effective Time each RSU held by the Reporting Person that was outstanding as of immediately prior to the Effective Time (whether or not vested) was automatically cancelled and converted into the right to receive an amount equal to the Scheme Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-308739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000119312525308739/ownership.xml","form_type":"4"}},{"id":1003882,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-10T18:30:04.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":7148,"price":2.09,"value":14939.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 14, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement that includes a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on December 22, 2023, and the sale does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 77,429 unvested restricted stock units."}],"balance_after":99290,"source":{"system":"sec-edgar","filing":"0001193125-25-274768","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000119312525274768/ownership.xml","form_type":"4"}},{"id":1223085,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-05T16:47:11.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 3, 2025. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on March 1, 2026 and the remaining 75% of the underlying ordinary shares shall vest in 12 equal quarterly installments thereafter, subject to the reporting person's continued services with the Issuer."}],"balance_after":65000,"derivative":{"exercise_price":3.43,"expiration_date":"2035-03-02","underlying":"Ordinary Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000950170-25-033761","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017025033761/ownership.xml","form_type":"4"}},{"id":1223084,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-05T16:47:11.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of ordinary shares issuable under 35,000 restricted stock units (\"RSUs\"). Each RSU represents the right to receive one ordinary share upon vesting. The RSUs are scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of March 1, 2025, subject to the reporting person's continued service with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 59,144 unvested restricted stock units."}],"balance_after":106438,"source":{"system":"sec-edgar","filing":"0000950170-25-033761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017025033761/ownership.xml","form_type":"4"}},{"id":1378307,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-01T07:04:51.000Z","date":"2024-10-31","kind":"sale","planned":true,"acquired":false,"shares":7421,"price":3.41,"value":25305.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Reporting Person to satisfy withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 14, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement that includes a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 12, 2024, and the sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.49. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 59,144 unvested restricted stock units."}],"balance_after":71438,"source":{"system":"sec-edgar","filing":"0000950170-24-119800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017024119800/ownership.xml","form_type":"4"}},{"id":1707632,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-12-18T16:30:19.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":146452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on December 14, 2023. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on October 30, 2024 and the remaining 75% of the underlying ordinary shares shall vest in 12 equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer."}],"balance_after":146452,"derivative":{"exercise_price":3.61,"expiration_date":"2033-12-13","underlying":"Ordinary Shares","underlying_shares":146452},"source":{"system":"sec-edgar","filing":"0000950170-23-071115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017023071115/ownership.xml","form_type":"4"}},{"id":1707631,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-12-18T16:30:19.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":78859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of ordinary shares issuable under 78,859 restricted stock units (\"RSUs\"). Each RSU represents the right to receive one ordinary share upon vesting. The RSUs are scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of October 30, 2023, subject to the reporting person's continued service with the Issuer."}],"balance_after":78859,"source":{"system":"sec-edgar","filing":"0000950170-23-071115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017023071115/ownership.xml","form_type":"4"}},{"id":2427425,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Expiration)","published_at":"2022-01-24T16:17:00.000Z","date":"2022-01-24","kind":"other","acquired":false,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Converted from the Canadian dollar exercise price of C$3.63 using an exchange rate of C$1.2554 = $US1.00"}],"balance_after":16122,"derivative":{"exercise_price":2.89,"exercise_date":"2016-07-26","expiration_date":"2022-01-24","underlying":"Common shares","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001213900-22-003330","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1722673/000121390022003330/ownership.xml","form_type":"4"}},{"id":2427424,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Expiration)","published_at":"2022-01-24T16:17:00.000Z","date":"2022-01-24","kind":"other","acquired":false,"shares":1515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from the Canadian dollar exercise price of C$4.62 using an exchange rate of C$1.2554 = $US1.00"}],"balance_after":38849,"derivative":{"exercise_price":3.68,"exercise_date":"2015-11-27","expiration_date":"2022-01-24","underlying":"Common shares","underlying_shares":1515},"source":{"system":"sec-edgar","filing":"0001213900-22-003330","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1722673/000121390022003330/ownership.xml","form_type":"4"}},{"id":2427423,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Expiration)","published_at":"2022-01-24T16:17:00.000Z","date":"2022-01-24","kind":"other","acquired":false,"shares":6061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$4.79 using an exchange rate of C$1.2554 = $US1.00"}],"balance_after":40364,"derivative":{"exercise_price":3.82,"exercise_date":"2015-11-23","expiration_date":"2022-01-24","underlying":"Common shares","underlying_shares":6061},"source":{"system":"sec-edgar","filing":"0001213900-22-003330","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722673/000121390022003330/ownership.xml","form_type":"4"}},{"id":2455945,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-30T18:00:40.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/29/2021 and will vest 100% on the one year anniversary of the grant date (Dec 29, 2022) or immediately prior to the next AGM, whichever is sooner."}],"balance_after":46425,"derivative":{"exercise_price":1.32,"expiration_date":"2026-12-28","underlying":"Common shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001213900-21-068182","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722673/000121390021068182/ownership.xml","form_type":"4"}},{"id":2853954,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-17T17:02:41.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 15, 2022, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over the following 36 months."}],"balance_after":125000,"derivative":{"exercise_price":14.05,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-21-006915","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924321006915/doc4.xml","form_type":"4"}},{"id":2907681,"issuer":{"id":107761,"kind":"organization","name":"NAVIDEA BIOPHARMACEUTICALS, INC.","symbol":"NAVB"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2021-01-14T16:36:19.000Z","date":"2021-01-13","kind":"grant","acquired":true,"shares":2500,"price":0.001,"value":2.5,"ownership":{"direct":true},"balance_after":2500,"derivative":{"exercise_price":2.28,"exercise_date":"2022-01-13","expiration_date":"2031-01-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001437749-21-000727","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/810509/000143774921000727/rdgdoc.xml","form_type":"4"}},{"id":2907680,"issuer":{"id":107761,"kind":"organization","name":"NAVIDEA BIOPHARMACEUTICALS, INC.","symbol":"NAVB"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-01-14T16:36:19.000Z","date":"2021-01-13","kind":"grant","acquired":true,"shares":2500,"price":0.001,"value":2.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the one-year anniversary of the date of grant."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-21-000727","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/810509/000143774921000727/rdgdoc.xml","form_type":"4"}},{"id":2937243,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-18T06:16:38.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted on 12/16/2020 and will vest 100% on the one year anniversary of the grant date (Dec 16, 2021) or immediately prior to the next AGM, whichever is sooner."}],"balance_after":7000,"derivative":{"exercise_price":3.02,"expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001213900-20-043360","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722673/000121390020043360/ownership.xml","form_type":"4"}},{"id":3266442,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-18T21:59:32.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 14, 2021, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months."}],"balance_after":150000,"derivative":{"exercise_price":14.5,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-20-004989","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924320004989/doc4.xml","form_type":"4"}},{"id":3285541,"issuer":{"id":107761,"kind":"organization","name":"NAVIDEA BIOPHARMACEUTICALS, INC.","symbol":"NAVB"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2020-02-07T16:10:40.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":2500,"price":0.001,"value":2.5,"ownership":{"direct":true},"balance_after":7500,"derivative":{"exercise_price":1.06,"exercise_date":"2021-02-06","expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001437749-20-002030","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/810509/000143774920002030/rdgdoc.xml","form_type":"4"}},{"id":3285540,"issuer":{"id":107761,"kind":"organization","name":"NAVIDEA BIOPHARMACEUTICALS, INC.","symbol":"NAVB"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-07T16:10:40.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":2500,"price":0.001,"value":2.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the one-year anniversary of the date of grant."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001437749-20-002030","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/810509/000143774920002030/rdgdoc.xml","form_type":"4"}},{"id":3645154,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-20T16:32:04.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 15, 2020, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months."}],"balance_after":92000,"derivative":{"exercise_price":4.66,"expiration_date":"2029-02-15","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0000899243-19-004261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924319004261/doc4.xml","form_type":"4"}},{"id":3664333,"issuer":{"id":107761,"kind":"organization","name":"NAVIDEA BIOPHARMACEUTICALS, INC.","symbol":"NAVB"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2019-02-12T16:13:03.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":50000,"price":0.001,"value":50.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":0.25,"exercise_date":"2020-02-07","expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-19-002331","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/810509/000143774919002331/rdgdoc.xml","form_type":"4"}},{"id":3664332,"issuer":{"id":107761,"kind":"organization","name":"NAVIDEA BIOPHARMACEUTICALS, INC.","symbol":"NAVB"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-02-12T16:13:03.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":50000,"price":0.001,"value":50.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the one-year anniversary of the date of grant."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001437749-19-002331","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/810509/000143774919002331/rdgdoc.xml","form_type":"4"}},{"id":3711365,"issuer":{"id":107761,"kind":"organization","name":"NAVIDEA BIOPHARMACEUTICALS, INC.","symbol":"NAVB"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2019-01-03T16:26:10.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":50000,"price":0.001,"value":50.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":0.75,"exercise_date":"2020-01-02","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-19-000184","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/810509/000143774919000184/rdgdoc.xml","form_type":"4"}},{"id":3711364,"issuer":{"id":107761,"kind":"organization","name":"NAVIDEA BIOPHARMACEUTICALS, INC.","symbol":"NAVB"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-01-03T16:26:10.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":50000,"price":0.001,"value":50.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the one-year anniversary of the date of grant."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001437749-19-000184","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/810509/000143774919000184/rdgdoc.xml","form_type":"4"}},{"id":3908009,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T16:19:03.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option shall vest on May 31, 2019, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months."}],"balance_after":100000,"derivative":{"exercise_price":6.31,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-18-014898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924318014898/doc4.xml","form_type":"4"}},{"id":4161975,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":72154,"kind":"person","name":"Cutler Adam D.","position":1,"cik":"0001722673","reported_name":"Cutler Adam D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2017-11-15T12:37:58.000Z","date":"2017-11-13","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option shall vest on November 13, 2018, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months."}],"balance_after":225000,"derivative":{"exercise_price":8.05,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-17-026315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924317026315/doc4.xml","form_type":"4"}}]}